Axsome Therapeutics (NASDAQ: AXSM) grants director 1,721 restricted stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Coleman Mark reported acquisition or exercise transactions in this Form 4 filing.

Axsome Therapeutics director Mark Coleman received a grant of 1,721 restricted stock units. Each RSU represents a contingent right to receive one share of Axsome common stock. The award vests in full on the one-year anniversary of the grant date, after which the underlying common shares become deliverable, increasing his equity-based compensation stake in the company.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Coleman Mark

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	1,721	$0.00	--

Holdings After Transaction: Restricted Stock Units — 1,721 shares (Direct, null)

Footnotes (1)

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in full on the one-year anniversary of the date of grant.

Key Figures

RSU grant size: 1,721 units Underlying shares: 1,721 shares Vesting schedule: One-year cliff +1 more

4 metrics

RSU grant size 1,721 units Restricted stock units granted to director Mark Coleman

Underlying shares 1,721 shares Common stock deliverable upon RSU vesting

Vesting schedule One-year cliff RSUs vest in full on one-year anniversary of grant

Post-transaction RSUs 1,721 units Total RSUs held in this award after the transaction

Key Terms

Restricted Stock Units, RSU, contingent right, vest in full

4 terms

Restricted Stock Units financial

"security_title: "Restricted Stock Units""

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU financial

"Each restricted stock unit ("RSU") represents a contingent right"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

contingent right financial

"represents a contingent right to receive one share of the Issuer's common stock"

vest in full financial

"The RSUs vest in full on the one-year anniversary of the date of grant."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/09/2026 - 05:19 PM Accepted by SEC EDGAR 06/09/2026 - 05:18 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coleman Mark

(Last)

(First)

(Middle)

C/O AXSOME THERAPEUTICS, INC.

ONE WORLD TRADE CENTER, 29TH FLOOR

(Street)

NEW YORK

10007

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Axsome Therapeutics, Inc. [ AXSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	06/05/2026		A		1,721		⁽²⁾	⁽²⁾	Common Stock	1,721	$0	1,721	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. The RSUs vest in full on the one-year anniversary of the date of grant.

	/s/ Nick Pizzie, Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Axsome Therapeutics (AXSM) director Mark Coleman report on this Form 4?

Mark Coleman reported receiving a grant of 1,721 restricted stock units as equity compensation. These RSUs give him the right to receive an equal number of Axsome common shares once they vest, increasing his future share-based ownership in the company.

How many Axsome Therapeutics (AXSM) restricted stock units did Mark Coleman receive?

Mark Coleman received 1,721 restricted stock units from Axsome Therapeutics. Each unit represents a right to obtain one share of common stock, so the grant covers 1,721 underlying shares, subject to the vesting schedule described in the award terms.

When do Mark Coleman’s Axsome (AXSM) restricted stock units vest?

The restricted stock units granted to Mark Coleman vest in full on the one-year anniversary of the grant date. After this one-year vesting period, he becomes entitled to receive one share of Axsome common stock for each vested RSU, assuming continued eligibility.

Does the Form 4 for Axsome (AXSM) show Mark Coleman buying or selling shares?

The Form 4 does not show open-market buying or selling. It reports an acquisition of 1,721 restricted stock units as a grant or award, meaning the company granted equity compensation rather than Coleman purchasing or selling existing Axsome shares.

How many Axsome (AXSM) restricted stock units does Mark Coleman hold after this grant?

After this grant, Mark Coleman’s total reported holding for this RSU award is 1,721 units. These RSUs correspond to 1,721 underlying Axsome common shares, which will be delivered if and when the units vest according to the one-year vesting schedule.